Olopatadine Hydrochloride Solution
Product Images NDC 16571-861

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Olopatadine Hydrochloride (NDC 16571-861). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Olapatadine-0.2-carton.jpg (Olapatadine 0.2 Carton)

FDA Label Image

Olapatadine-0.2-container.jpg (Olapatadine 0.2 Container)

Olapatadine-0.2-container.jpg (Olapatadine 0.2 Container)
This text is a description of an eye allergy itch relief medication in the form of a solution. It provides instructions for use and storage conditions. The product is manufactured for Rising Pharma Holdings, Inc. in East Brunswick, NJ, USA, and it is made in India. The medication contains Olopatadine Hydrochloride and is indicated for once-daily relief of symptoms. The packaging dimensions are 68mm in length and 18mm in width. Additionally, it mentions a pharmacode reading and includes space for printing batch details such as LOT and EXP. The text also addresses tamper evident measures to ensure product safety.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.